Clinical implications of intestinal stem cell markers in colorectal cancer

Maiken Lise Marcker Espersen, Jesper Olsen, Dorte Linnemann, Estrid Høgdall, Jesper T Troelsen

33 Citations (Scopus)


Colorectal cancer (CRC) still has one of the highest incidence and mortality rate among cancers. Therefore, improved differential diagnostics and personalized treatment are still needed. Several intestinal stem cell markers have been found to be associated with CRC and might have a prognostic and predictive significance in CRC patients. This review provides an overview of the intestinal stem cell markers leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5), B cell-specific Moloney murine leukemia virus insertion site 1 (BMI1), Musashi1 (MSI1), and sex-determining region y-box 9 (SOX9) and their implications in human CRC. The exact roles of the intestinal stem cell markers in CRC development and progression remain unclear; however, high expression of these stem cell markers have a potential prognostic significance and might be implicated in chemotherapy resistance.

Original languageEnglish
JournalClinical Colorectal Cancer
Issue number2
Pages (from-to)63-71
Number of pages9
Publication statusPublished - Jun 2015


  • Animals
  • Colorectal Neoplasms
  • Humans
  • Intestines
  • Neoplastic Stem Cells


Dive into the research topics of 'Clinical implications of intestinal stem cell markers in colorectal cancer'. Together they form a unique fingerprint.

Cite this